Enviar búsqueda
Cargar
Material Transfer Agreements
•
1 recomendación
•
238 vistas
N
ndbaf03
Seguir
Denunciar
Compartir
Denunciar
Compartir
1 de 3
Descargar ahora
Descargar para leer sin conexión
Recomendados
дошкольники
дошкольники
tenshova
ASEAN benchmarking in terms of science, technology, and innovation from 1999 ...
ASEAN benchmarking in terms of science, technology, and innovation from 1999 ...
ndbaf03
EU Innovation Policies
EU Innovation Policies
ndbaf03
Ethics, Accounting and Auditing
Ethics, Accounting and Auditing
ndbaf03
Study On The Quality Of The Patent System in Europe En
Study On The Quality Of The Patent System in Europe En
ndbaf03
Access to data and material for research: putting empirical evidence into per...
Access to data and material for research: putting empirical evidence into per...
ndbaf03
Role and dynamics of corporate R&D
Role and dynamics of corporate R&D
ndbaf03
“ DOING BUSINESS IN A CROSS-CULTURAL ENVIRONMENT”
“ DOING BUSINESS IN A CROSS-CULTURAL ENVIRONMENT”
ndbaf03
Recomendados
дошкольники
дошкольники
tenshova
ASEAN benchmarking in terms of science, technology, and innovation from 1999 ...
ASEAN benchmarking in terms of science, technology, and innovation from 1999 ...
ndbaf03
EU Innovation Policies
EU Innovation Policies
ndbaf03
Ethics, Accounting and Auditing
Ethics, Accounting and Auditing
ndbaf03
Study On The Quality Of The Patent System in Europe En
Study On The Quality Of The Patent System in Europe En
ndbaf03
Access to data and material for research: putting empirical evidence into per...
Access to data and material for research: putting empirical evidence into per...
ndbaf03
Role and dynamics of corporate R&D
Role and dynamics of corporate R&D
ndbaf03
“ DOING BUSINESS IN A CROSS-CULTURAL ENVIRONMENT”
“ DOING BUSINESS IN A CROSS-CULTURAL ENVIRONMENT”
ndbaf03
Accessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit research
Bhavitha Pulaparthi
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptx
Mastewal7
Laying out the Principles of Open Science
Laying out the Principles of Open Science
Kaitlin Thaney
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
Kevin E. Flynn
Feb Biocom panel
Feb Biocom panel
Erica Pascal
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Rafael Escalona Reynoso
Legal Framework For E Research
Legal Framework For E Research
legal4
Accessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofit
Bhavitha Pulaparthi
Ddt Ontologies And Drug Discovery
Ddt Ontologies And Drug Discovery
sgardne0
India's patent laws under pressure
India's patent laws under pressure
brandsynapse
Material Transfer Agreements
Material Transfer Agreements
Marcel Mongeon
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
legalservices
protecting innovation
protecting innovation
Razwand
Pe0710 Lead Indicators
Pe0710 Lead Indicators
gbashe
Responsabilidades Eticas Acta Tropica2009
Responsabilidades Eticas Acta Tropica2009
guestaf9d7594
2013 Open PHACTS Scientific Questions Poster
2013 Open PHACTS Scientific Questions Poster
open_phacts
Ppt3 181219044715
Ppt3 181219044715
erlambang00
CAT- 2001
CAT- 2001
Vasista Vinuthan
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SterneKessler
Berlin 6 Open Access Conference: Philippe Aigrain
Berlin 6 Open Access Conference: Philippe Aigrain
Cornelius Puschmann
Más contenido relacionado
Similar a Material Transfer Agreements
Accessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit research
Bhavitha Pulaparthi
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptx
Mastewal7
Laying out the Principles of Open Science
Laying out the Principles of Open Science
Kaitlin Thaney
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
Kevin E. Flynn
Feb Biocom panel
Feb Biocom panel
Erica Pascal
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Rafael Escalona Reynoso
Legal Framework For E Research
Legal Framework For E Research
legal4
Accessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofit
Bhavitha Pulaparthi
Ddt Ontologies And Drug Discovery
Ddt Ontologies And Drug Discovery
sgardne0
India's patent laws under pressure
India's patent laws under pressure
brandsynapse
Material Transfer Agreements
Material Transfer Agreements
Marcel Mongeon
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
legalservices
protecting innovation
protecting innovation
Razwand
Pe0710 Lead Indicators
Pe0710 Lead Indicators
gbashe
Responsabilidades Eticas Acta Tropica2009
Responsabilidades Eticas Acta Tropica2009
guestaf9d7594
2013 Open PHACTS Scientific Questions Poster
2013 Open PHACTS Scientific Questions Poster
open_phacts
Ppt3 181219044715
Ppt3 181219044715
erlambang00
CAT- 2001
CAT- 2001
Vasista Vinuthan
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SterneKessler
Berlin 6 Open Access Conference: Philippe Aigrain
Berlin 6 Open Access Conference: Philippe Aigrain
Cornelius Puschmann
Similar a Material Transfer Agreements
(20)
Accessing other people’s technology for nonprofit research
Accessing other people’s technology for nonprofit research
pharmacoepidemiology individual assignment..pptx
pharmacoepidemiology individual assignment..pptx
Laying out the Principles of Open Science
Laying out the Principles of Open Science
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
The CREATE Act -- As viewed from the Ivory Towers and from the Trenches
Feb Biocom panel
Feb Biocom panel
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Are Intellectual Property Rights Evolving Towards the Enclosure of the 'Intan...
Legal Framework For E Research
Legal Framework For E Research
Accessing other people’s technology for nonprofit
Accessing other people’s technology for nonprofit
Ddt Ontologies And Drug Discovery
Ddt Ontologies And Drug Discovery
India's patent laws under pressure
India's patent laws under pressure
Material Transfer Agreements
Material Transfer Agreements
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
Adams The Legalized Crime Of Banking And A Constitutional Remedy (1958)
protecting innovation
protecting innovation
Pe0710 Lead Indicators
Pe0710 Lead Indicators
Responsabilidades Eticas Acta Tropica2009
Responsabilidades Eticas Acta Tropica2009
2013 Open PHACTS Scientific Questions Poster
2013 Open PHACTS Scientific Questions Poster
Ppt3 181219044715
Ppt3 181219044715
CAT- 2001
CAT- 2001
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
SKGF_Advisory_Stem Cells-Patent Pools to the Rescue_2005
Berlin 6 Open Access Conference: Philippe Aigrain
Berlin 6 Open Access Conference: Philippe Aigrain
Material Transfer Agreements
1.
P AT E
N T S Material transfer agreements: open science vs. © 2005 Nature Publishing Group http://www.nature.com/naturebiotechnology proprietary claims Victor Rodriguez For academia and industry, MTAs are the means to widely differing ends. A lthough the development of pharmaceuti- cal and biotechnological end products has been traditionally based on patents, biomedical impose research restrictions that infringe upon academic freedom or the dissemination of research results, and may conflict with spe- look to inventions as a basis for royalties. Since research materials may have important com- mercial value, their transfer is treated much the research in academia comes from the very dif- cific requirements of funding agreements. same as a transfer of patent rights1. ferent tradition of open science; that is, relatively MTAs are contracts that are protected by law. unrestricted access to fundamental knowledge If one of their provisions is not followed, the Standardization and variables developed by previous researchers. Research contract is breached and the wronged party In the United States, to simplify transfers materials were often freely exchanged without has the right to bring action against the other, between nonprofit research institutions, the formal arrangements. Beginning in the 1970s, such as suing for damages. The transferred National Institutes of Health (NIH) published in however, life science research brought academia material under an agreement may also be pro- 1995 the final version of the Uniform Biological and industry closer together. tected against certain forms of violation by Material Transfer Agreement (UBMTA) and the Industry defends its commercial and prop- third parties. Thus, a third party who obtains Simple Letter Agreement for the Transfer of erty interests by acquiring and protecting the material by theft or trickery may be liable Non-Proprietary Biological Material. Although exclusivity in the market through patents and for damages. there has been no formal agreement on a for- trade secrets. In contrast, governments and the In industry, MTAs will authorize the mat for use when a for-profit entity is provid- academics they fund aim to preserve the flow exchange of materials between collaborating ing material to a nonprofit organization, the of ideas through publication or to safeguard companies for the purpose of developing a Association of University Technology Managers the creation of a product thanks to the new product, prohibit the materials’ use or trans- (AUTM), the NIH and industry representa- knowledge. Sometimes these two missions fer to third parties for purposes other than the tives from what was then the Pharmaceutical conflict, as in the case of material transfer collaboration, and define a mechanism for Manufacturers Association developed a draft agreements (MTAs). marketing the product. Patent and ownership agreement in 1992. rights will be precisely defined, but problems At the 2003 AUTM annual meeting, a spe- MTAs in practice sometimes arise concerning the allocation of cial interest group on MTAs met for the first Pioneered by industry, MTAs are used in rights to unexpected inventions arising from time and made a survey of significant issues for connection with the transfer of materials for the research. A typical solution is for each party academia and industry. For academia, the most safekeeping purposes (for instance, storage to receive a nonexclusive license to any inven- significant issues relating to MTAs were: the in gene banks), research or commercial use. tion emerging from the joint effort. The com- nonexclusive royalty-free license, with the right Now increasingly being used by public sec- mercial value of such a license is often small; to sublicense; the broad definition of materi- tor laboratories and academia, they may take hence, companies may not attempt to obtain als; the publication restriction; the invention a variety of forms, from letters accompany- patents on such material. ownership of recipients; the indemnification; ing a shipment of materials to detailed and Nonprofit research units, such as public sec- the tracking and honoring obligations to the formally negotiated contracts signed by both tor and academic laboratories, want to ensure provider; and the definition of invention. For parties before a transfer of materials is made that the material remains in the public domain industry, the most important matters were: in or out of research units. Outbound agree- while making certain that their association unauthorized distribution and publication2. ments are often associated with having pat- with the material is recognized. Two factors The provisions of MTAs may vary, depending ent rights to the material in question, whereas are leading nonprofit research institutions to on the intentions of the parties (see Table 1). At inbound agreements may include terms that adopt different strategies. First, exclusivity— one extreme, MTAs may be designed to avoid obtained through intellectual property (IP) patent rights on the material or its components. rights—is necessary to ensure that the mate- At the other, they encourage patenting inven- Victor Rodriguez is in the Department of Applied rial can be commercialized. Companies will tions deriving from the material and dividing Economics, Catholic University of Leuven, not use public sector inventions unless they the benefits of such inventions. For academia, Naamsestraat 69, 3000 Leuven, Belgium. can recoup the costs involved in taking them the basic restriction is the limitation to pub- e-mail: victor.rodriguez@econ.kuleuven.be to market. Second, nonprofit research units lish research results. The agreement wording NATURE BIOTECHNOLOGY VOLUME 23 NUMBER 4 APRIL 2005 489
2.
PAT E N
T S Table 1 Characteristics of material transfer agreements used by nonprofit and for-profit parties Nonprofit party For-profit party Advantages Availability of research materials at no cost Access to expertise not available within company; collaborative opportunity Disadvantages Conflicting obligations to provider and financial sponsor; Loss of control over materials; loss of competitive edge due to freedom to publish not always guaranteed; usage restric- publications tions difficult to track Definitions of material Narrow definition that includes unmodified derivatives, Broad definition that includes unmodified derivatives, variants © 2005 Nature Publishing Group http://www.nature.com/naturebiotechnology but excludes variants and confidential information and confidential information Use of material Indetermination of noncommercial research; distinction Control of asset distribution; limited use to laboratory; return of between use and transfer of modified material unused material License rights Broad, free nonexclusives with right to sublicense; Royalty-free, nonexclusives with limited sub-licensable right; in forced joint ownership a problem joint inventions, mutual permission necessary to license to third parties Pre-license patent prosecution The provider should bear all costs of patent prosecution In sole inventions of recipient, the recipient bears costs and gets in return for option grant; split costs for joint inventions recouped under exclusive license; in joint inventions parties split not equitable costs Post-license patent prosecution It is preferable to control prosecution; alternative, right It is preferable to control patent prosecution and make patent to veto actions that undermine ownership interests; the decisions, freedom to operate in return for bearing risk of devel- licensor (recipient) has the right to continue prosecution opment; alternative, if ownership interest is impacted, nonprofit on its own and the licensee (provider) loses right if this can pursue prosecution no longer pays patent costs Confidentiality Avoid obligation if possible; identify clearly in writing all Written broadly; need to protect corporate assets; competitive confidential information; may permeate research making environment requires maintaining confidentiality; balance risk publication difficult; need exceptions, e.g., for indepen- against benefit; preserve opportunity for patent protection dent development; should not include research results or data generated by investigator Publication Acceptable delays for review, before submission; accept- Limited time delays before submission or to file patents; pre- able restriction on content, none to confidential informa- serve confidentiality of confidential information tion and thesis issues Term and termination The provider has the right to terminate problematic situ- Freedom to terminate and lack of finite research term ations if the material has been used in thesis research; the term on research makes it easier to monitor ongoing obligations Source: reference 2 may give the provider control of publication material, implying that the provider is not deterring factor, the agreement can include and may assert that nothing is to be published responsible, even if the material was provided the proposal of a one-time fee to allow for cost or otherwise disclosed without the provider’s without proper warnings about associated haz- recovery. Such a fee can reasonably include the approval, to allow the provider to determine ards or needed precautions. cost of materials, the extra labor required to whether its own confidential information has Equitable ownership of materials is deter- make them, and shipping or other fees3. been improperly disclosed, and whether there mined in much the same way as ownership of When the material transfer occurs before the are new IP rights. IP. Difficulties may arise when an academic filing of a patent application related to the trans- Providers may also assert ownership not only investigator uses two materials from two dif- ferred materials, such a transfer may be deemed of the physical material, but also of new materi- ferent providers, or has made one of the mate- prior art to the claims and bar patentability of als or inventions made by recipients through the rials under company sponsorship. In such a the transferred materials. Although most cur- use of the provided materials. This not only rep- situation, it is quite likely that the terms of the rently used academic MTAs are adequate for resents a direct loss, but also can cause indirect agreements covering the two materials are in post-filing transfers, confidentiality provisions damage by limiting the freedom of recipients conflict. If preemptive MTAs cloud owner- may be required to avoid the prior art effect of to continue a line of inquiry because they no ship rights, investigators may be restricted in some pre-filing transfers. Whether a pre-filing longer own their research results. An agreement their ability to interact with a future sponsor. transfer of an invention whose full utility is not may award the provider an automatic license for Investigators may need a commercial developer known bars patentability awaits future clarifica- the resulting IP for little or no compensation, to convert an invention into a product, but IP tion by the courts. so that it can develop commercial products if terms in MTAs may prevent the institution Additionally, when pre-filing transfers are it chooses. Since the provider of the material is from granting rights to a future developer. No made, agreements lacking confidentiality provi- usually not funding the research, the recipient sponsor wants to pay for research benefits that sions may negatively affect academic technology needs to ensure that there are no conflicting it cannot have. In addition, the terms of an transfer. First, if a patent is invalidated because obligations between its financial sponsors and agreement may make it difficult to collaborate of such transfers, the institution may not be the provider. with other scientists. entitled to royalties from the claimed invention An agreement term may require that the Some materials can be very costly to make, from the licensee. Second, those transfers may recipient indemnify the provider against any and it can be financially unreasonable to sup- be used by prospective licensees to discount the damage that may occur through use of the ply them to multiple investigators. If this is a value of the patent, even if a patent has not been 490 VOLUME 23 NUMBER 4 APRIL 2005 NATURE BIOTECHNOLOGY
3.
PAT E N
T S challenged. Third, after discovering those trans- ity does not depend on vigilance. Without tion in setting the terms of their agreements fers, a would-be licensee may abandon licensing some monitoring or tracking, MTAs may be and tailoring them to their specific needs. negotiations and develop the technology with- effectively meaningless. Transferred material can be regarded as trade out a license, knowing that, if sued for patent secrets. In countries that protect trade secret infringement, an attack on the patent validity Looking ahead contracts, MTAs offer a form of IP protection could arise. The proprietary claiming wave has been the that can go beyond that available under pat- MTAs are enforceable in countries that consequence of high levels of investment in ent law. The increasing complexity involved respect trade secret law. A caveat can arise R&D and extraordinary scientific and techno- in the supply of proprietary technologies may from competition law that restricts the use logical breakthroughs. Although IP rights may raise matters of contract law, IP law, biodiver- © 2005 Nature Publishing Group http://www.nature.com/naturebiotechnology of private agreements to achieve IP goals far sometimes be necessary to motivate industry sity and biosafety law, technology transfer and beyond those created by patent and copyright to develop and disseminate university-based competition law. statutes. But it is not clear whether in order inventions, the trend towards the assertion of ACKNOWLEDGMENTS to be enforceable, the agreement has to be IP rights by universities may also impede the The author would like to thank Jean Gilbert for helpful signed by both parties before the transfer progress of science. The challenge lies in distin- comments on drafts of this article. of the material, or whether a simple letter guishing research results that are better devel- included with the transferred material is suf- oped and disseminated through open access or 1. Barton J.H. & Siebeck W.E. Material transfer agree- ficient to establish an enforceable agreement. under the protection of IP rights. Despite the ments in genetic resources exchange: the case of the If the recipient proposes terms that materially fact that MTAs provide a safeguard for invest- international agricultural research centers. Issues in Genetic Resources No. 1 (International Plant Genetic differ from those contained in the letter of ments in technology by setting out the condi- Resources Institute, Rome, 1994). agreement, the response, even if it is worded tions for using the material, open science is 2. Streitz W.D. et al. Material transfer agreements: a win- win for academia and industry. Annual meeting of the as acceptance, is considered a new offer, to be limited by MTAs. AUTM (AUTM, Northbrook, 2003). accepted by the provider. Finally, there is no Unlike patents or copyrights, MTAs do not 3. Council of Governmental Relations. Material Transfer legal requirement for the provider to verify rest upon codified legal statutes defining spe- in Academia (COGR, Washington, 1997). 4. Whitaker, J.S. The prior art effect of material transfer whether the recipient is living up to obliga- cific rights and obligations. Instead, reflecting agreements. J. Assoc. Univ. Technol. Managers VI, tions included in the agreement; enforceabil- freedom of contract, parties have wide discre- 1–10 (1994). NATURE BIOTECHNOLOGY VOLUME 23 NUMBER 4 APRIL 2005 491
Descargar ahora